BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6166404)

  • 1. [Results of calcitonin therapy of the painful symptoms caused by osteolytic metastases of prostatic carcinoma].
    Fabris P; Strada G; Tonazzi G; Rossi A; Franchini V; Scardino E
    Chir Ital; 1980 Dec; 32(6):1740-4. PubMed ID: 6166404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A 63-year-old otherwise healthy patient with bone metastatic prostate carcinoma of one year duration, with osteolytic metastasis to the left os pubis, os ischii and acetabulum].
    Internist (Berl); 1996 May; 37(5):521-3. PubMed ID: 9011554
    [No Abstract]   [Full Text] [Related]  

  • 3. [Synthetic salmon calcitonin in the therapeutic management of osteolytic metastases of breast carcinoma].
    Simone C; Racanelli A
    Clin Ter; 1981 Aug; 98(3):247-67. PubMed ID: 7285537
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-pain effect of salmon calcitonin in bone metastases of malignant tumors with the exception of breast and prostatic carcinoma].
    Jelić S; Borkovacki R; Babović N; Kovcin V; Milanović N
    Vojnosanit Pregl; 1995; 52(2):151-4. PubMed ID: 7571528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer.
    Heidenreich A; Hofmann R; Engelmann UH
    J Urol; 2001 Jan; 165(1):136-40. PubMed ID: 11125382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
    Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Wnts in prostate cancer bone metastases.
    Hall CL; Kang S; MacDougald OA; Keller ET
    J Cell Biochem; 2006 Mar; 97(4):661-72. PubMed ID: 16447163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salmon calcitonin for bone pain in patients with metastatic carcinoma of the prostate. A pilot study.
    Kadow C; Gingell JC
    Br J Clin Pract; 1988 Jan; 42(1):24-5. PubMed ID: 2461728
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combination of P32 and testosterone in the treatment of pain due to osseous metastasis of prostate neoplasms].
    García de la Peña E; Sánchez Martín JA; Linazasoro JM; Cifuentes Delatte L
    Rev Clin Esp; 1974 Sep; 134(6):527-34. PubMed ID: 4141512
    [No Abstract]   [Full Text] [Related]  

  • 10. [Eel calcitonin treatment on patients with urogenital carcinoma for relief of pain from metastatic bone lesions].
    Noguchi K; Kubota Y; Moriyama M; Kinoshita Y; Hosaka M; Kondo I; Fukushima S; Fujii H; Miyai K; Satomi Y
    Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2577-86. PubMed ID: 2614193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low-dose cisplatin on 89Sr therapy for painful bone metastases from prostate cancer: a randomized clinical trial.
    Sciuto R; Festa A; Rea S; Pasqualoni R; Bergomi S; Petrilli G; Maini CL
    J Nucl Med; 2002 Jan; 43(1):79-86. PubMed ID: 11801708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients.
    Rodrigues P; Hering F; Campagnari JC
    Prostate Cancer Prostatic Dis; 2004; 7(4):350-4. PubMed ID: 15534620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Medical treatment of bone metastases].
    Tubiana-Hulin M
    Bull Cancer Radiother; 1996; 83(4):299-304. PubMed ID: 9081331
    [No Abstract]   [Full Text] [Related]  

  • 14. Salmon calcitonin in the treatment of bone metastases.
    Serdengeçti S; Serdengeçti K; Derman U; Berkarda B
    Int J Clin Pharmacol Res; 1986; 6(2):151-5. PubMed ID: 3721646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical use of calcitonin in the treatment of osseous localizations in breast carcinoma and multiple myeloma].
    Di Benedetto G; Corsini G; Puppo F; Zavarise GM
    Clin Ter; 1981 Mar; 96(6):605-13. PubMed ID: 7285526
    [No Abstract]   [Full Text] [Related]  

  • 16. [Successful relief of severe pain from bone metastases of carcinoma of the prostate by the treatment with P32].
    Nakaarai K; Tokizane M; Okuda N; Ito S
    Hinyokika Kiyo; 1966 Dec; 12(12):1429-34. PubMed ID: 4167082
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of combined intravenous and oral clodronate treatment on bone pain in patients with metastatic prostate cancer.
    Kylmälä T; Tammela TL; Lindholm TS; Seppänen J
    Ann Chir Gynaecol; 1994; 83(4):316-9. PubMed ID: 7537482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experience with human calcitonin].
    De Bastiani G; Nogarin L; Lazzaretto R
    Minerva Med; 1981 Jun; 72(26):1719-23. PubMed ID: 6166901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy is a cost-effective palliative treatment for patients with bone metastasis from prostate cancer.
    Konski A
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1373-8. PubMed ID: 15590167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethics forum. 75-year-old man has end-stage prostate cancer with metastases to bone.
    Rich BA; Casarett D; Battin MP
    Pain Med; 2005; 6(6):459-63. PubMed ID: 16336483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.